CN103860764A - Traditional Chinese medicine for treating central retinal artery obstruction and preparation method thereof - Google Patents
Traditional Chinese medicine for treating central retinal artery obstruction and preparation method thereof Download PDFInfo
- Publication number
- CN103860764A CN103860764A CN201410091111.8A CN201410091111A CN103860764A CN 103860764 A CN103860764 A CN 103860764A CN 201410091111 A CN201410091111 A CN 201410091111A CN 103860764 A CN103860764 A CN 103860764A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- radix
- radix rehmanniae
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating central retinal artery obstruction. The traditional Chinese medicine is characterized by being prepared from the following medicinal materials in parts by weight: 12-15 parts of Chinese wolfberry, 8-10 parts of chrysanthemum, 8-10 parts of rehmannia root, 8-10 parts of prepared rehmannia root, 12-15 parts of angelica, 8-10 parts of red peony root, 8-10 parts of Szechuan lovage rhizome, 8-10 parts of motherwort fruits, 25-30 parts of phoenix hawksbeard root, 8-10 parts of fructus aurantii, 8-10 parts of lumbricus, 10-12 parts of glossy privet fruits, 0-30 parts of clematis finetiana and 0-9 parts of straight-flowered corydalis. A preparation method comprises the steps of weighing the medicinal materials, putting the medicinal materials into a container, adding water of which the quantity is 8 times that of the medicinal materials, decocting for 1.5 hours, and filtering; adding water of which the quantity is 6 times that of filter residues into the filter residues, decocting for 1 hour, and filtering; and combining the filtrates, concentrating, drying, and filling capsule shells with the dried mixture. Clinical experiments prove that the traditional Chinese medicine achieves a significant effect of treating the central retinal artery obstruction by selecting the appropriate medicinal materials and the ratio thereof, is safe and does not have toxic or side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of Chinese medicine that is used for the treatment of central retinal artery occlusion and preparation method thereof.
Background technology
Central retinal artery occlusion is to cause blind serious oculopathy a kind of moment, and the traditional Chinese medical science is called " sudden blindness ".Primary disease, because the trunk of Zinn's artery or its branch block, makes its region of supplying that acute ischemia, anoxia occur, and causes this district's nutrition to be cut off and causes malfunction extremely, primary disease morbidity is anxious, obtain and must rescue immediately after being ill, seize every minute and second, otherwise will cause permanent loss vision.Clinically be more common in simple eyely, be also found in occasionally bilateral, morbidity people is comparatively common with middle-aged and elderly people.The traditional Chinese medical science thinks that primary disease is how terrified because of rage, and mechanism of qi is disorderly contrary, bleeding resulting from adverse flow of QI, QI and blood closing; Or depressed emotion, the liver losing its smoothly moving state, qi depression to blood stasis, order network blocks; Or hobby tobacco and wine, addiction to greasy and sweet foods, expectorant Re Neisheng, due to upper heap soil or fertilizer over and around the roots order key.Treatment for central retinal artery occlusion still lacks the effective medicine of generally recognized as safe at present.
Summary of the invention
The present invention aims to provide a kind of Chinese medicine that is used for the treatment of central retinal artery occlusion and preparation method thereof, by selecting suitable medical material and proportioning thereof, reaches the remarkable efficacy of effective treatment central retinal artery occlusion, and safe without toxic side effect.
In order to achieve the above object, the present invention is by the following technical solutions: a kind of Chinese medicine that is used for the treatment of central retinal artery occlusion, is prepared from by the medical material of following weight proportion: 12～15 parts of Fructus Lyciis, 8～10 parts of Flos Chrysanthemis, 8～10 parts, the Radix Rehmanniae, 8～10 parts, Radix Rehmanniae Preparata, 12～15 parts of Radix Angelicae Sinensis, 8～10 parts of Radix Paeoniae Rubra, 8～10 parts of Rhizoma Chuanxiongs, 8～10 parts of Fructus Leonuris, 25～30 parts of Crepis crocea Babc.(C.turczaninowii C.A.Mey.)s, 8～10 parts of Fructus Aurantiis, 8～10 parts of Pheretimas, 10～12 parts of Fructus Ligustri Lucidi, 0～30 part of Caulis Clematidis Finetianae, 0～9 part of Herba Corydalis tailensis.
As preferably, be prepared from by the medical material of following weight proportion: 15 parts of Fructus Lyciis, 10 parts of Flos Chrysanthemis, 10 parts, the Radix Rehmanniae, 10 parts, Radix Rehmanniae Preparata, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Paeoniae Rubra, 10 parts of Rhizoma Chuanxiongs, 10 parts of Fructus Leonuris, 30 parts of Crepis crocea Babc.(C.turczaninowii C.A.Mey.)s, 10 parts of Fructus Aurantiis, 10 parts of Pheretimas, 12 parts of Fructus Ligustri Lucidi.
As preferably, be prepared from by the medical material of following weight proportion: 15 parts of Fructus Lyciis, 10 parts of Flos Chrysanthemis, 10 parts, the Radix Rehmanniae, 10 parts, Radix Rehmanniae Preparata, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Paeoniae Rubra, 10 parts of Rhizoma Chuanxiongs, 10 parts of Fructus Leonuris, 30 parts of Crepis crocea Babc.(C.turczaninowii C.A.Mey.)s, 10 parts of Fructus Aurantiis, 10 parts of Pheretimas, 12 parts of Fructus Ligustri Lucidi, 30 parts of Caulis Clematidis Finetianaes.
As preferably, be prepared from by the medical material of following weight proportion: 15 parts of Fructus Lyciis, 10 parts of Flos Chrysanthemis, 10 parts, the Radix Rehmanniae, 10 parts, Radix Rehmanniae Preparata, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Paeoniae Rubra, 10 parts of Rhizoma Chuanxiongs, 10 parts of Fructus Leonuris, 30 parts of Crepis crocea Babc.(C.turczaninowii C.A.Mey.)s, 10 parts of Fructus Aurantiis, 10 parts of Pheretimas, 12 parts of Fructus Ligustri Lucidi, 9 parts of Herba Corydalis tailensiss.
As preferably, be prepared from by the medical material of following weight proportion: 15 parts of Fructus Lyciis, 10 parts of Flos Chrysanthemis, 10 parts, the Radix Rehmanniae, 10 parts, Radix Rehmanniae Preparata, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Paeoniae Rubra, 10 parts of Rhizoma Chuanxiongs, 10 parts of Fructus Leonuris, 30 parts of Crepis crocea Babc.(C.turczaninowii C.A.Mey.)s, 10 parts of Fructus Aurantiis, 10 parts of Pheretimas, 12 parts of Fructus Ligustri Lucidi, 30 parts of Caulis Clematidis Finetianaes, 9 parts of Herba Corydalis tailensiss.
A kind of preparation method of the Chinese medicine that is used for the treatment of central retinal artery occlusion, comprise the steps: to take Fructus Lycii, Flos Chrysanthemi, the Radix Rehmanniae, Radix Rehmanniae Preparata, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Fructus Leonuri, Crepis crocea Babc.(C.turczaninowii C.A.Mey.), Fructus Aurantii, Pheretima, Fructus Ligustri Lucidi, Caulis Clematidis Finetianae, Herba Corydalis tailensis, insert in container, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, incapsulate shell.
As preferably, comprise the steps: to take Fructus Lycii, Flos Chrysanthemi, the Radix Rehmanniae, Radix Rehmanniae Preparata, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Fructus Leonuri, Crepis crocea Babc.(C.turczaninowii C.A.Mey.), Fructus Aurantii, Pheretima, Fructus Ligustri Lucidi, Caulis Clematidis Finetianae, Herba Corydalis tailensis, insert in container, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, dry, then add appropriate dextrin and correctives, granulate according to this area common process.
As preferably, comprise the steps: to take Fructus Lycii, Flos Chrysanthemi, the Radix Rehmanniae, Radix Rehmanniae Preparata, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Fructus Leonuri, Crepis crocea Babc.(C.turczaninowii C.A.Mey.), Fructus Aurantii, Pheretima, Fructus Ligustri Lucidi, Caulis Clematidis Finetianae, Herba Corydalis tailensis, insert in container, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, concentrated, dry, pulverize.
The pharmacology analysis of the each Chinese medicinal ingredients of the present invention is as follows:
The dry mature fruit of Fructus Lycii [source] plant of Solanaceae lycium barbarum.[nature and flavor] are sweet, flat.[return through] returns liver, kidney channel.[function cures mainly] nourishing the liver and kidney, replenishing vital essence to improve eyesight.
Flos Chrysanthemi [source] this product is the dry capitulum of feverfew chrysanthemum.[nature and flavor] are sweet, bitter, are slightly cold.[return through] returns lung, Liver Channel.[function cures mainly] the wind heat clearing away of faling apart, suppressing the hyperactive liver improving eyesight.For anemopyretic cold, have a headache dizzy, conjunctival congestion and swelling pain, eyes is dim-sighted.
Fresh or the dried root that the Radix Rehmanniae [source] this product is scrophulariaceae rehmannia glutinosa plant.[nature and flavor] Radix Rehmanniae: sweet, cold.[return through] GUIXIN, liver, kidney channel.[function cures mainly] clearing away heat and cooling blood, yin nourishing, promotes the production of body fluid.For calentura crimson tongue excessive thirst, yin asthenia generating intrinsic heat, hectic fever due to YIN-deficiency consumptive fever, interior-heat is quenched one's thirst, and spits blood, and epistaxis, sends out speckle dermexanthesis.
The Preparation process product that Radix Rehmanniae Preparata [source] this product is Radix Rehmanniae.[nature and flavor] are sweet, tepor.[return through] returns liver, kidney channel.[function cures mainly] nourishing YIN and supplementing blood, beneficial essence is filled out marrow.For the hepatic and renal YIN deficiency, soreness of the waist and knees, osteopyrexia and fever, night sweat seminal emission, interior-heat is quenched one's thirst, blood deficiency and yellow complexion, severe palpitation, menoxenia, metrostaxis, dizzy, tinnitus, early whitening of beard and hair.
The dry root of Radix Angelicae Sinensis [source] umbelliferae angelica.[nature and flavor] sweet, acrid, warm.[return through] returns liver, the heart, spleen channel.[function cures mainly] enriched blood and invigorated blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.For blood deficiency and yellow complexion, dizzy cardiopalmus, menoxenia, amenorrhea dysmenorrhea, asthenia cold abdominalgia, dryness of the intestine constipation, rheumatic arthralgia, injury from falling down, ulcer sores.Radix Angelicae Sinensis (processed with wine) promoting blood circulation to restore menstrual flow.For amenorrhea dysmenorrhea, rheumatic arthralgia, injury from falling down.
The dry root of Radix Paeoniae Rubra [source] ranunculaceae plant Radix Paeoniae or river Radix Paeoniae Rubra.[nature and flavor] hardship, is slightly cold.[return through] returns Liver Channel.[function cures mainly] clearing away heat and cooling blood, eliminating stasis to stop pain.For maculae caused by violent heat pathogen, hematemesis and epistaxis, conjunctival congestion and swelling pain, hypochondriac pain due to stagnation of liverQI, amenorrhea dysmenorrhea, lump in the abdomen stomachache, injury from falling down, carbuncle skin infection.
The dry rhizome of Rhizoma Chuanxiong [source] samphire Rhizoma Chuanxiong.[nature and flavor] are pungent, temperature.[return through] returns liver, gallbladder, pericardium channel.[function cures mainly] blood-activating and qi-promoting, wind-expelling pain-stopping.
The dry mature fruit of Fructus Leonuri [source] labiate Herba Leonuri.[nature and flavor] are pungent, bitter, are slightly cold.[return through] GUIXIN bag, Liver Channel.[function cures mainly] promoting blood flow to regulate menstruation, liver heat removing and eyesight improving.For menoxenia, amenorrhea, dysmenorrhea, conjunctival congestion cataracta, dizzy distending pain.
The root of Crepis crocea Babc.(C.turczaninowii C.A.Mey.) [source] feverfew Crepis phoenix Dunn, autumn, winter uproot, and clean, and section, dries.[nature and flavor] hardship, temperature.[function cures mainly] invigorating the liver and kidney, strengthening the spleen increases breast.Control infantile malnutrition, anemia, leucorrhea, edema, hepatitis, hypogalactia, traumatic injury, discharging fresh blood stool.
The dry immature fruit of Fructus Aurantii [source] rutaceae Citrus aurantium Linn. and variety thereof.[function cures mainly] regulating the flow of QI to ease the stomach, the stagnant relieving distension of row.For the breast side of body stagnation of QI, distension pain, accumulation of food in the stomach and intes tine due to indigestion, stops in phlegm retention; Gastroptosis, proctoptosis, sub-official's prolapsus.
Pheretima [source] this product is the dry body of Ju Yin section animal Pheretima aspergillum.[nature and flavor] are salty, cold.[return through] returns liver, spleen, urinary bladder channel.[function cures mainly] heat clearing away arresting convulsion, dredging collateral, relievings asthma, diuresis.For unconsciousness due to high fever, infantile convulsion is twitched, arthralgia, numb limbs and tense tendons, hemiplegia, dyspnea and cough due to lung-heat, oliguria edema, hypertension.
The dry mature fruit of Fructus Ligustri Lucidi [source] Oleaceae plants Fructus Ligustri Lucidi.[nature and flavor] sweet, bitter, cold.[return through] returns liver, kidney channel.[function cures mainly] nourishing the liver and kidney, improving eyesight black hair.For vertigo and tinnitus, soreness of the waist and knees, early whitening of beard and hair, poor vision.
Caulis Clematidis Finetianae [source] is root, stem, the leaf of ranunculaceae plant Caulis Clematidis Finetianae.[nature and flavor] hardship, temperature.[function cures mainly] expelling wind and removing dampness, promoting blood circulation and detoxication.Dispelling the wind and dampness pathogens arthralgia, gastroenteritis, malaria, acute mastitis, ulcerative gingivitis, punctate keratitis.
Herba Corydalis tailensis [source] is the herb of bloodroot Herba Corydalis tailensis.[nature and flavor] hardship; [return through] liver is slightly cold; Lung meridian.[function cures mainly] dispels the wind; Heat clearing away; Pain relieving; Liver heat removing and eyesight improving.Main anemopyretic cold; Cough due to lung-heat; Pulmonary tuberculosis hemoptysis; Hepatitis; Fengshi Guanjie bones and muscles pain; Toothache; Conjunctival congestion; Cataracta.
Below in conjunction with clinical experiment data declaration beneficial effect of the present invention:
Through clinical patient's 92 examples of accepting central retinal artery occlusion for medical treatment, take the oral agents of making according to embodiment 1, two doses of every days, use continuously 5-15 days.Therapeutic evaluation: cure: transference cure; Effective: symptom alleviates, but do not disappear completely; Invalid: symptom does not disappear, without obviously changing.
Therapeutic outcome: cure and effective totally 79 examples, effective percentage, up to 85.9%, is followed up a case by regular visits to after March again, all without recurrence.
Detailed description of the invention
In order to understand better and to implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: 15 parts of Fructus Lyciis, 10 parts of Flos Chrysanthemis, 10 parts, the Radix Rehmanniae, 10 parts, Radix Rehmanniae Preparata, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Paeoniae Rubra, 10 parts of Rhizoma Chuanxiongs, 10 parts of Fructus Leonuris, 30 parts of Crepis crocea Babc.(C.turczaninowii C.A.Mey.)s, 10 parts of Fructus Aurantiis, 10 parts of Pheretimas, 12 parts of Fructus Ligustri Lucidi, 30 parts of Caulis Clematidis Finetianaes, 9 parts of Herba Corydalis tailensiss, insert in container, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merge filtrate twice, concentrated.
Be used for the treatment of central retinal artery occlusion.Oral, two doses of every days.
Embodiment 2
Take: 15 parts of Fructus Lyciis, 10 parts of Flos Chrysanthemis, 10 parts, the Radix Rehmanniae, 10 parts, Radix Rehmanniae Preparata, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Paeoniae Rubra, 10 parts of Rhizoma Chuanxiongs, 10 parts of Fructus Leonuris, 30 parts of Crepis crocea Babc.(C.turczaninowii C.A.Mey.)s, 10 parts of Fructus Aurantiis, 10 parts of Pheretimas, 12 parts of Fructus Ligustri Lucidi, 30 parts of Caulis Clematidis Finetianaes, 9 parts of Herba Corydalis tailensiss, insert in container, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Filtering residue adds 2 times of water gagings, decocts 1 hour, filters; Merge three times filtrate, concentrated.
Be used for the treatment of central retinal artery occlusion.Oral, two doses of every days.
Embodiment 3
Take: 15 parts of Fructus Lyciis, 10 parts of Flos Chrysanthemis, 10 parts, the Radix Rehmanniae, 10 parts, Radix Rehmanniae Preparata, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Paeoniae Rubra, 10 parts of Rhizoma Chuanxiongs, 10 parts of Fructus Leonuris, 30 parts of Crepis crocea Babc.(C.turczaninowii C.A.Mey.)s, 10 parts of Fructus Aurantiis, 10 parts of Pheretimas, 12 parts of Fructus Ligustri Lucidi, 30 parts of Caulis Clematidis Finetianaes, 9 parts of Herba Corydalis tailensiss, insert in container, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merge filtrate twice, concentrated.
Be used for the treatment of central retinal artery occlusion.Oral, two doses of every days.
Obviously, the above embodiment of the present invention is only for example of the present invention is clearly described, and is not the restriction to embodiments of the present invention.For those of ordinary skill in the field, can also make other changes in different forms on the basis of the above description.Here cannot give exhaustive to all embodiments.Everyly belong to apparent variation or the still row in protection scope of the present invention of variation that technical scheme of the present invention extends out.
Claims (8)
1. one kind is used for the treatment of the Chinese medicine of central retinal artery occlusion, it is characterized in that, be prepared from by the medical material of following weight proportion: 12～15 parts of Fructus Lyciis, 8～10 parts of Flos Chrysanthemis, 8～10 parts, the Radix Rehmanniae, 8～10 parts, Radix Rehmanniae Preparata, 12～15 parts of Radix Angelicae Sinensis, 8～10 parts of Radix Paeoniae Rubra, 8～10 parts of Rhizoma Chuanxiongs, 8～10 parts of Fructus Leonuris, 25～30 parts of Crepis crocea Babc.(C.turczaninowii C.A.Mey.)s, 8～10 parts of Fructus Aurantiis, 8～10 parts of Pheretimas, 10～12 parts of Fructus Ligustri Lucidi, 0～30 part of Caulis Clematidis Finetianae, 0～9 part of Herba Corydalis tailensis.
2. a kind of Chinese medicine that is used for the treatment of central retinal artery occlusion according to claim 1, it is characterized in that, be prepared from by the medical material of following weight proportion: 15 parts of Fructus Lyciis, 10 parts of Flos Chrysanthemis, 10 parts, the Radix Rehmanniae, 10 parts, Radix Rehmanniae Preparata, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Paeoniae Rubra, 10 parts of Rhizoma Chuanxiongs, 10 parts of Fructus Leonuris, 30 parts of Crepis crocea Babc.(C.turczaninowii C.A.Mey.)s, 10 parts of Fructus Aurantiis, 10 parts of Pheretimas, 12 parts of Fructus Ligustri Lucidi.
3. a kind of Chinese medicine that is used for the treatment of central retinal artery occlusion according to claim 1, it is characterized in that, be prepared from by the medical material of following weight proportion: 15 parts of Fructus Lyciis, 10 parts of Flos Chrysanthemis, 10 parts, the Radix Rehmanniae, 10 parts, Radix Rehmanniae Preparata, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Paeoniae Rubra, 10 parts of Rhizoma Chuanxiongs, 10 parts of Fructus Leonuris, 30 parts of Crepis crocea Babc.(C.turczaninowii C.A.Mey.)s, 10 parts of Fructus Aurantiis, 10 parts of Pheretimas, 12 parts of Fructus Ligustri Lucidi, 30 parts of Caulis Clematidis Finetianaes.
4. a kind of Chinese medicine that is used for the treatment of central retinal artery occlusion according to claim 1, it is characterized in that, be prepared from by the medical material of following weight proportion: 15 parts of Fructus Lyciis, 10 parts of Flos Chrysanthemis, 10 parts, the Radix Rehmanniae, 10 parts, Radix Rehmanniae Preparata, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Paeoniae Rubra, 10 parts of Rhizoma Chuanxiongs, 10 parts of Fructus Leonuris, 30 parts of Crepis crocea Babc.(C.turczaninowii C.A.Mey.)s, 10 parts of Fructus Aurantiis, 10 parts of Pheretimas, 12 parts of Fructus Ligustri Lucidi, 9 parts of Herba Corydalis tailensiss.
5. a kind of Chinese medicine that is used for the treatment of central retinal artery occlusion according to claim 1, it is characterized in that, be prepared from by the medical material of following weight proportion: 15 parts of Fructus Lyciis, 10 parts of Flos Chrysanthemis, 10 parts, the Radix Rehmanniae, 10 parts, Radix Rehmanniae Preparata, 15 parts of Radix Angelicae Sinensis, 10 parts of Radix Paeoniae Rubra, 10 parts of Rhizoma Chuanxiongs, 10 parts of Fructus Leonuris, 30 parts of Crepis crocea Babc.(C.turczaninowii C.A.Mey.)s, 10 parts of Fructus Aurantiis, 10 parts of Pheretimas, 12 parts of Fructus Ligustri Lucidi, 30 parts of Caulis Clematidis Finetianaes, 9 parts of Herba Corydalis tailensiss.
6. one kind is used for the treatment of the preparation method of the Chinese medicine of central retinal artery occlusion, it is characterized in that, comprise the steps: to take Fructus Lycii, Flos Chrysanthemi, the Radix Rehmanniae, Radix Rehmanniae Preparata, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Fructus Leonuri, Crepis crocea Babc.(C.turczaninowii C.A.Mey.), Fructus Aurantii, Pheretima, Fructus Ligustri Lucidi, Caulis Clematidis Finetianae, Herba Corydalis tailensis, insert in container, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, incapsulate shell.
7. the preparation method of a kind of Chinese medicine that is used for the treatment of central retinal artery occlusion according to claim 6, it is characterized in that, comprise the steps: to take Fructus Lycii, Flos Chrysanthemi, the Radix Rehmanniae, Radix Rehmanniae Preparata, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Fructus Leonuri, Crepis crocea Babc.(C.turczaninowii C.A.Mey.), Fructus Aurantii, Pheretima, Fructus Ligustri Lucidi, Caulis Clematidis Finetianae, Herba Corydalis tailensis, insert in container, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, dry, then add appropriate dextrin and correctives, granulate according to this area common process.
8. the preparation method of a kind of Chinese medicine that is used for the treatment of central retinal artery occlusion according to claim 6, it is characterized in that, comprise the steps: to take Fructus Lycii, Flos Chrysanthemi, the Radix Rehmanniae, Radix Rehmanniae Preparata, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Fructus Leonuri, Crepis crocea Babc.(C.turczaninowii C.A.Mey.), Fructus Aurantii, Pheretima, Fructus Ligustri Lucidi, Caulis Clematidis Finetianae, Herba Corydalis tailensis, insert in container, add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, concentrated, dry, pulverize.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410091111.8A CN103860764A (en) | 2014-03-12 | 2014-03-12 | Traditional Chinese medicine for treating central retinal artery obstruction and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410091111.8A CN103860764A (en) | 2014-03-12 | 2014-03-12 | Traditional Chinese medicine for treating central retinal artery obstruction and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103860764A true CN103860764A (en) | 2014-06-18 |
Family
ID=50900150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410091111.8A Pending CN103860764A (en) | 2014-03-12 | 2014-03-12 | Traditional Chinese medicine for treating central retinal artery obstruction and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103860764A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104523896A (en) * | 2014-12-10 | 2015-04-22 | 四川金堂海纳生物医药技术研究所 | Oral medicine for treating embolism central retinal artery and preparation method thereof |
| CN104666816A (en) * | 2015-02-12 | 2015-06-03 | 张宏国 | Traditional Chinese medicine preparation for treating retinal arterial obstruction |
| CN104740179A (en) * | 2015-03-03 | 2015-07-01 | 梁天齐 | Traditional Chinese medicine composition for treating obstruction of central rentinal artery |
| CN105477204A (en) * | 2016-01-11 | 2016-04-13 | 高淼淼 | Composition for adjuvant treatment on occlusion of central retinal artery and preparing method of composition |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1348815A (en) * | 2001-11-09 | 2002-05-15 | 天津天士力制药股份有限公司 | Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use |
| CN103211759A (en) * | 2013-03-28 | 2013-07-24 | 中国人民解放军军事医学科学院毒物药物研究所 | Puerarin nanocrystalline medical composition and preparation method thereof |
-
2014
- 2014-03-12 CN CN201410091111.8A patent/CN103860764A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1348815A (en) * | 2001-11-09 | 2002-05-15 | 天津天士力制药股份有限公司 | Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use |
| CN103211759A (en) * | 2013-03-28 | 2013-07-24 | 中国人民解放军军事医学科学院毒物药物研究所 | Puerarin nanocrystalline medical composition and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 江波等: "中西医结合治疗视网膜中央静脉阻塞临床观察", 《中国中医急症》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104523896A (en) * | 2014-12-10 | 2015-04-22 | 四川金堂海纳生物医药技术研究所 | Oral medicine for treating embolism central retinal artery and preparation method thereof |
| CN104666816A (en) * | 2015-02-12 | 2015-06-03 | 张宏国 | Traditional Chinese medicine preparation for treating retinal arterial obstruction |
| CN104740179A (en) * | 2015-03-03 | 2015-07-01 | 梁天齐 | Traditional Chinese medicine composition for treating obstruction of central rentinal artery |
| CN104740179B (en) * | 2015-03-03 | 2018-10-26 | 四川和光堂生物科技有限公司 | A kind of Chinese medicine composition for treating central retinal artery occlusion |
| CN105477204A (en) * | 2016-01-11 | 2016-04-13 | 高淼淼 | Composition for adjuvant treatment on occlusion of central retinal artery and preparing method of composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102657835B (en) | Composition and medical liquor for treatment of high blood pressure/rheumatoid arthritis and preparation method and application of composition and medical liquor | |
| CN102370878B (en) | Chinese medicinal oral preparation for treating aphthous stomatitis | |
| CN103860764A (en) | Traditional Chinese medicine for treating central retinal artery obstruction and preparation method thereof | |
| CN105497837A (en) | Traditional Chinese medicinal preparation with function of restoring white hair to black color and preparation method of traditional Chinese medicinal preparation | |
| CN103816344A (en) | Traditional Chinese medicine for treating presbycusis and preparation method of traditional Chinese medicine | |
| CN103860744B (en) | A kind of Chinese medicine being used for the treatment of central retinal vein occlusion and preparation method thereof | |
| CN103908543A (en) | Traditional Chinese medicine for treating sequelae of apoplexy and preparation method thereof | |
| CN103830593B (en) | A kind of Chinese medicine composition and external medicinal liquid thereof for the treatment of burn and scald | |
| CN103520352B (en) | The Chinese medicine for the treatment of stasis blocking venation pattern of syndrome obstruction of qi in the chest and cardialgia | |
| CN103830497A (en) | Traditional Chinese medicine for treating vitreous opacity and preparation method thereof | |
| CN103520631B (en) | Traditional Chinese medicine used for treating irregular menstruation | |
| CN103961433A (en) | Internal medicine for treating leucoderma and preparation method thereof | |
| CN103655902A (en) | Traditional Chinese medicine composition for preventing alopecia and preparation method thereof | |
| CN103816425A (en) | Traditional Chinese medicine for treating senile dementia and preparation method thereof | |
| CN103656199B (en) | A kind of Chinese medicine for the treatment of deficiency of kidney yin syndrome cough | |
| CN103520672B (en) | The Chinese medicine for the treatment of dampness-heat of the liver pattern of syndrome menopathy | |
| CN107551183A (en) | It is a kind of dispel pathogenic wind and remove dampness, the Chinese medicine composition of swelling and pain relieving and preparation method thereof | |
| CN105343859A (en) | Medicament for treating vertigo and preparation method of medicament | |
| CN104288689A (en) | Traditional Chinese medicine for treating mucocutaneous lymph node syndromes and preparation method of traditional Chinese medicine | |
| CN103830524A (en) | Traditional Chinese medicine for treating aphtha caused by deficiency of liver-yin and kidney-yin and hyperactivity of deficiency fire and preparation method thereof | |
| CN104983980A (en) | Traditional Chinese medicine for treating diabetic coprostasis | |
| CN104258087A (en) | Heat-clearing, blood-cooling and blood-stanching drug for woman menorrhagia and preparation method thereof | |
| CN104257934A (en) | Astringent traditional Chinese medicine preparation for woman menorrhagia and preparation method thereof | |
| CN103655846B (en) | Traditional Chinese medicine for treating gastric collateral stasis syndrome type gastroptosis | |
| CN103893440A (en) | Traditional Chinese medicine granules for treating ischemic papillopathy and detection method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140618 |